USPTO trademark

KENLIFABI

AllowedUSPTOWord markClass 5

"KENLIFABI" is a word mark owned by Idorsia Pharmaceuticals Ltd, filed at the USPTO on August 27, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
KENLIFABI trademark as filed
As filed with the USPTO
Status
Allowed
Since October 6, 2026
Filed
August 27, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99360014
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns KENLIFABI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services KENLIFABI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, for the treatment of glycolipid storage disorders, and for the treatment of cancer

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Teas change of correspondence received
  6. Teas withdrawal as domestic representative received
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Applicant/correspondence changes (non-responsive) entered
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About KENLIFABI

Who owns the trademark "KENLIFABI"?

The USPTO trademark "KENLIFABI" (application 99360014) is owned by Idorsia Pharmaceuticals Ltd.

What is the status of "KENLIFABI"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KENLIFABI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b1a-c1a0-72cc-9ab1-c97dffc84ee4
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b1a-c1a0-72cc-9ab1-c97dffc84ee4",
  "object": "trademark",
  "mark_text": "KENLIFABI",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99360014",
  "filing_date": "2025-08-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Idorsia Pharmaceuticals Ltd",
      "entity_id": "ent_019eb70d-61bd-7356-b4dd-4e764388378a"
    }
  ]
}